Internal Server Error

Us2.ai - About the company

Us2.ai is a series A company based in Singapore (Singapore), founded in 2017 by James Hare, Yoran M Hummel and Carolyn Lam. It operates as an AI-powered tool for the detection of heart risk. Us2.ai has raised $19.1M in funding from investors like EDBI, IHH Healthcare Berhad and HEAL Partners. The company has 570 active competitors, including 118 funded and 28 that have exited. Its top competitors include companies like HeartFlow, Oxipit and ScreenPoint.

Company Details

AI-powered tool for the detection of heart risk. The company's flagship product, Echo Copilot, provides automated, real-time echo reports and disease detection by strain imaging, Aortic stenosis measurements, quantitative analysis of cardiac structure and function supporting healthcare professionals in interpreting echocardiograms.
Website
us2.ai
Social
XFacebook
Email ID
*****@us2.ai
Phone Number
+65 **********
Part Of
Registered Address
CIRCULAR ROAD, Singapore, 49426
Key Metrics
Founded Year
2017
Location
Singapore, Singapore
Stage
Series A
Total Funding
$19.1M in 4 rounds
Latest Funding Round
Investors
Ranked
Annual Revenue
SGD 1M - 10M as on Jul 31, 2025
Employee Count
33 as on Sep 30, 2026
Similar Companies
Sign up to download Us2.ai's company profile

Us2.ai's funding and investors

Us2.ai has raised a total funding of $19.1M over 4 rounds. Its first funding round was on Sep 26, 2019. Its latest funding round was a Series A round on Apr 14, 2022 for $*****. 6 investors participated in its latest round. Us2.ai has 16 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Us2.ai:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Apr 14, 2022
8836705
Series A
7604958
5512521
4706740
5359047
Jan 07, 2020
7146830
Series A
8550476
4955301
7821652
Nov 13, 2019
7384959
Grant (prize money)
3197835
5899812
8314488
lockAccess funding benchmarks and valuations. Sign up today!

Us2.ai's founders and board of directors

Founder? Claim Profile
The founders of Us2.ai are James Hare, Yoran M Hummel and Carolyn Lam.
Here are the details of Us2.ai's key team members:

Us2.ai's Board of Directors

Us2.ai's board has 5 active members. James Hare and Lam Su Ping Carolyn are part of team and Pieter Kemps, Robinson Martin Eric and Elizabeth Han Yu are independent board members.
Here is the list of Us2.ai's board of directors:
Name
Type
Representing
Status
Duration
Team
-
Current
9y 1m
Team
-
Current
9y 1m
Independent board member
-
Current
6y 10m
blkpbgn
Independent board member
-
Current
6y 8m
upscjxh
Independent board member
-
Current
2y 2m

Us2.ai's employee count trend

Us2.ai has 33 employees as of Sep 26. Here is Us2.ai's employee count trend over the years:
Employee count trend for Us2.ai
lockUncover Us2.ai's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Us2.ai's Competitors and alternates

Top competitors of Us2.ai include HeartFlow, Oxipit and ScreenPoint. Here is the list of Top 10 competitors of Us2.ai, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for HeartFlow
HeartFlow
2007, Redwood City (United States), Public
Provides cardiovascular diagnostic support using analytics
$936M
69/100
2nd
Logo for Oxipit
Oxipit
2017, Vilnius (Lithuania), Acquired
Developer of medical imaging software for automated radiology diagnostic support
$6.69M
68/100
3rd
Logo for ScreenPoint
ScreenPoint
2014, Nijmegen (Netherlands), Series C
Developer of artificial intelligence software for analyzing breast imaging mammograms
$47M
65/100
4th
Logo for Optellum
Optellum
2015, Oxford (United Kingdom), Series A
Provider of AI-based cancer diagnostics platform
$20.6M
63/100
5th
Logo for Vista
Vista
2012, Palo Alto (United States), Series B
AI-guided software for clinicians to automate MRI exams
$38.2M
62/100
6th
Logo for Us2.ai
Us2.ai
2017, Singapore (Singapore), Series A
AI-powered tool for the detection of heart risk
$19.1M
61/100
7th
Logo for Olea Medical
Olea Medical
2008, La Ciotat (France), Acquired
Developer of medical diagnostic software solutions for image post-processing
$6.7M
61/100
8th
Logo for Elucid
Elucid
2013, Boston (United States), Series D
AI-based arterial analysis software for providers
$207M
61/100
9th
Logo for UltraSight
UltraSight
2018, Rehovot (Israel), Series B
AI-based platform providing ultrasound diagnosis for cardiac disorders
$38.1M
61/100
10th
Logo for Retinai Medical
Retinai Medical
2016, Bern (Switzerland), Series B
AI-based solutions for the diagnosis of retinal diseases
$15.7M
62/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Us2.ai's competitors? Click here to see the top ones

Us2.ai's Investments and acquisitions

Us2.ai has made no investments or acquisitions yet.

News related to Us2.ai

lockFilter this list
Media has covered Us2.ai for 1 event in last 1 year, It was about partnerships.
•
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Us2.ai

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford